Job Mongare, MD | |
113 N Murchison St, Athens, TX 75751-2109 | |
(903) 677-6006 | |
(903) 677-9006 |
Full Name | Job Mongare |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 30 Years |
Location | 113 N Murchison St, Athens, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962463869 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | K8954 (Texas) | Secondary |
174400000X | Specialist | K8954 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cedar Lake Home Health And Hospice | Malakoff, TX | Home health agency |
Ut Health East Texas Athens Hospital | Athens, TX | Hospital |
Ut Health East Texas Tyler Regional Hospital | Tyler, TX | Hospital |
Mailing Address | Practice Location Address |
---|---|
Job Mongare, MD 113 N Murchison St, Athens, TX 75751-2109 Ph: (903) 677-6006 | Job Mongare, MD 113 N Murchison St, Athens, TX 75751-2109 Ph: (903) 677-6006 |
News Archive
The New York Times explores how congressional staffs are anxious about a health law provision requiring them to buy coverage in online insurance markets because the federal government may no longer pay a share of their premiums.
Twins may look alike on the outside, but not so much on the inside. That's one takeaway from a new preprint study posted to the medRxiv server where Brazilian researchers observed different T-cell responses in two pairs of identical twins exposed to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One twin who was reinfected with SARS-CoV-2 four months after had low recognition of CD4+ and CD8+ T-cell epitopes.
The nation's preterm birth rate dropped for the second consecutive year.
Government officials said Wednesday during a Capitol Hill hearing that the Oct. 1 deadline may not allow enough time to test the systems that are being put in place to run these online insurance marketplaces.
EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.
› Verified 9 days ago